logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
R

Richard B. Warren

dermatology centre

69H-index
698Paper Count
1.7WCitation Count
Published Papers 343
Publication Date
logo
Deucravacitinib 5-Year Safety and Efficacy Results in Plaque Psoriasis: A Phase 3 Open-Label Extension of Randomized Clinical Trials
errAmerican Journal of Clinical Dermatology
IF8.8
err2026-08-07
err0
errOAAI
errApril W. Armstrong; Mark Lebwohl; Richard B. Warren; Akimichi Morita; Carle Paul; Diamant Thaçi; Matthias Augustin; Lluís Puig; Carolin Daamen; Janice Li; Alessandra Alió; Angela Aggrey-Amable; Julie Scotto; Zoran Popmihajlov; John Vaile; Bruce Strober
errShare
errSave
Cost-Utility Analyses of Systemic Treatments for Psoriasis and Psoriatic Arthritis in the UK: A Systematic Review of Modelling Methods
errPharmacoeconomics
IF4.6
err2026-07-08
err0
PREAI
errThomas S. Clemmet; Duc Binh Phan; Alice Copson; Richard B. Warren; Zenas Z. N. Yiu; Gabriel Rogers
errShare
errSave
Serious infection risk with systemic treatments for psoriasis: A cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
errBritish Journal of Dermatology
IF9.6
err2026-05-05
err0
PREAI
errHeber Rew Bright Bright; Catherine H Smith; Philip Laws; Nick J Reynolds; Duc Binh Phan; Mark Lunt; Richard B Warren; Zenas Z N Yiu
errShare
errSave
Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study
errClinical and Translational Science
IF2.8
err2026-04-30
err0
errOAAI
errShan Pan; Teresa Tsakok; Ruoheng Wei; Nick Dand; Floris C. Loeff; Karien Bloem; Annick de Vries; David Baudry; Michael Duckworth; Angela Pushpa-Rajah; Alice Russell; Ali Alsharqi; Gabrielle Becher; Ruth Murphy; Shyamal Wahie; Andrew Wright; Christopher E. M. Griffiths; Nick J. Reynolds; Jonathan Barker; Richard B. Warren; A. David Burden; Theo Rispens; Satveer K. Mahil; Joseph F. Standing; Catherine H. Smith; the BADBIR Study Group; the BSTOP Study Group and the PSORT Consortium
errShare
errSave
Long-Term Safety and Efficacy of Tralokinumab in Patients with Moderate-to-Severe Atopic Dermatitis Treated for up to 6 Years: Final Results from the Open-Label Extension Trial ECZTEND
errDermatology and Therapy
IF4.2
err2026-02-05
err0
errOAAI
errAndrew Blauvelt; H. Chih-Ho Hong; Norito Katoh; Richard G. Langley; Vivian Laquer; Aleksandra Lesiak; Ketty Peris; Julien Seneschal; Juan-Francisco Silvestre; Richard B. Warren; Andreas Wollenberg; Matthew Zirwas; Niels Højsager Bennike; Farzaneh Safavimanesh; Ann-Marie Tindberg; Kristian Reich
errShare
errSave
Bimekizumab Efficacy and Safety in Patients with Psoriatic Arthritis with Substantial Skin and Nail Psoriasis to 1 Year
errDermatology and Therapy
IF4.2
err2025-12-12
err0
errOAAI
errDiamant Thaçi; Akihiko Asahina; Wolf-Henning Boehncke; Alice B. Gottlieb; Mark Lebwohl; Richard B. Warren; Heather Edens; Barbara Ink; Rajan Bajracharya; Jason Coarse; Joseph F. Merola
errShare
errSave
Lebrikizumab for the Treatment of Moderate to Severe Atopic Eczema: Real-World Experience from a Tertiary Centre
errDermatology and Therapy
IF4.2
err2025-12-06
err0
errOAAI
errAzmeralda Abraheem; Neenu Sebastian; Firas C. Kreeshan; Tim H. Clayton; Hamish J. A. Hunter; Richard B. Warren
errShare
errSave
Deucravacitinib in Plaque Psoriasis After Inadequate Response to Apremilast: Phase 3 POETYK Analysis
errDermatology and Therapy
IF4.2
err2025-12-05
err0
errOAAI
errApril W. Armstrong; Richard B. Warren; Howard Sofen; Lynda Spelman; Misti Linaberry; Brandon Becker; Ying-Ming Jou; Carolin Daamen; Alexa B. Kimball
errShare
errSave
Is Cumulative Life Course Impairment Considered in Psoriasis Management? A Multinational Survey of People with Psoriasis and Healthcare Professionals
errDermatology and Therapy
IF4.2
err2025-11-22
err0
errOAAI
errRaymond Matthews; April W. Armstrong; Matthias Augustin; Christopher Baker; José Manuel Carrascosa; Brian Kirby; Richard Langley; Sandy McBride; Adam Reich; Ricardo Romiti; Francesca Sampogna; Richard B. Warren
errShare
errSave
Targeted Oral Peptide Icotrokinra for Psoriasis Involving High-Impact Sites
errNEJM Evidence
IF0
err2025-11-01
err3
PREAI
errGooderham, Melinda; Lain, Edward; Bissonnette, Robert; Huang, Yu-Huei; Lynde, Charles W.; Hoffmann, Matthias; Song, Eingun James; Weirich, Oliver; Ceitlin, Raul Hernan Gabriel; Rubens, Jessica H.; Delozier, Amy M.; Ota, Takayuki; Hsu, Ming-Chun; Li, Shu; Deklotz, Cynthia M. C.; Nunes, Fabio; Warren, Richard B.
errShare
errSave
Safety of tralokinumab in patients with moderate-to-severe atopic dermatitis followed for up to 4.5 years: an integrated analysis of eight clinical trials
errBRITISH JOURNAL OF DERMATOLOGY
IF9.6
err2025-11-01
err1
errOAAI
errReich, Kristian; Langley, Richard G.; Silvestre Salvador, Juan Francisco; Staumont-Salle, Delphine; Costanzo, Antonio; Pink, Andrew E.; Paller, Amy S.; Katoh, Norito; Wollenberg, Andreas; Warren, Richard B.; Blauvelt, Andrew; Bjerregard Oland, Christian; Tindberg, Ann-Marie; Gjerum, Le; Simpson, Eric L.
errShare
errSave
Bimekizumab Efficacy in Psoriasis by Subgroups: Post Hoc Analysis of Phase 3/3b Clinical Trials
errDermatology and Therapy
IF4.2
err2025-10-08
err0
errOAAI
errBruce Strober; Wolf-Henning Boehncke; James G. Krueger; Nina Magnolo; Ronald Vender; Richard B. Warren; José Manuel López Pinto; Sarah Kavanagh; Bengt Hoepken; Paolo Gisondi
errShare
errSave
Serious Infection Risk with Systemic Treatments for Psoriasis: A Systematic Review and Network Meta-analysis Combining Randomised and Non-randomised Evidence
errDERMATOLOGY AND THERAPY
IF4.2
err2025-10-01
err0
errOAAI
errBright, Heber Rew Bright; Phan, Duc Binh; Zahid, Amna; Aval, Leila Motedayen; Manupati, Shilpa; Smith, Catherine H.; Exton, Lesley S.; Ezejimofor, Martinsixtus; Lunt, Mark; Warren, Richard B.; Yiu, Zenas Z. N.
errShare
errSave
Orismilast, a Potent and Selective PDE4B/D Inhibitor, Reduces Protein Levels of Key Disease Driving Cytokines in the Skin of Patients With Plaque Psoriasis
errEXPERIMENTAL DERMATOLOGY
IF3.1
err2025-09-19
err0
errOAAI
errWarren, Richard B.; Weiss, Anne; Felding, Jakob; Sommer, Morten O. A.; Garcet, Sandra; Krueger, James G.
errShare
errSave
Efficacy and safety of lebrikizumab in adult and adolescent patients with moderate-to-severe atopic dermatitis inadequately controlled with or ineligible for ciclosporin A: a placebo-controlled, randomized phase IIIb clinical study (ADvantage)
errBRITISH JOURNAL OF DERMATOLOGY
IF9.6
err2025-09-01
err1
PREAI
errWarren, Richard B.; de Bruin-Weller, Marjolein; Tsianakas, Athanasios; Khemis, Abdallah; Szepietowski, Jacek C.; Hong, H. Chih-ho; Mihaylov, Yanislav; Falques, Meritxell; Agell, Helena; Massana, Eric; Gil, Esther Garcia; Coll, Ruth; Weidinger, Stephan
errShare
errSave
Bimekizumab Complete Clearance of Both Skin and Nail Psoriasis: Comparative Efficacy in Phase III/IIIb Studies
errAmerican Journal of Clinical Dermatology
IF8.8
err2025-08-31
err0
errOAAI
errJoseph F. Merola; Richard B. Warren; Diamant Thaçi; Kenneth B. Gordon; Emi Nishida; Bruce Strober; Curdin Conrad; Sarah Kavanagh; José Manuel López Pinto; Bengt Hoepken; Paolo Gisondi
errShare
errSave
Mendelian randomization identifies OX40 as a potential mediator of the effects of cigarette smoking on palmoplantar pustulosis
errBRITISH JOURNAL OF DERMATOLOGY
IF9.6
err2025-08-01
err0
errOAAI
errSmail, Alice; Dand, Nick; Liu, Xinyue; Burden, A. David; Baudry, David; Griffiths, Christopher E. M.; Pink, Andrew; Reynolds, Nick J.; Warren, Richard B.; Barker, Jonathan N.; Smith, Catherine H.; Capon, Francesca
errShare
errSave
Predictors of differential treatment response between adalimumab and methotrexate in psoriasis: a causal forest analysis of the British Association of Dermatologists Biologics and Immunomodulators Register
errBRITISH JOURNAL OF DERMATOLOGY
IF9.6
err2025-07-01
err0
errOAAI
errHaw, William W. Y.; Alabas, Oras A.; Sperrin, Matthew; Cina, Giovanni; Abu-Hanna, Ameen; Warren, Richard B.
errShare
errSave
(P002) Predicting psoriasis biologic drug discontinuation: an explainable machine learning approach applying British Association of Dermatologists Biologics and Immunomodulators Register data
errBRITISH JOURNAL OF DERMATOLOGY
IF9.6
err2025-07-01
err0
errOAAI
errHussain, Amaani B.; Iqbal, Wasim; Atallah, Christian; Warren, Richard B.; Barnes, Michael; Missier, Paolo; Reynolds, Nick J.
errShare
errSave
Asthma control in patients receiving systemic therapy for atopic eczema: results from the UK Atopic eczema Systemic TherApy Register (A-STAR)
errBRITISH JOURNAL OF DERMATOLOGY
IF9.6
err2025-07-01
err0
errOAAI
errTsoi, Man Fung; Gribaleva, Elizaveta; Prieto-Merino, David; Carroll, Rebecca; Coker, Bolaji; Baden, Manisha; Beattie, Paula E.; Burton, Tim; Hearn, Ross; Ingram, John R.; Irvine, Alan D.; Johnston, Graham A.; Man, Irene; Ogg, Graham; Wan, Mandy; Warren, Richard B.; Woolf, Richard T.; Reynolds, Nick J.; Ardern-Jones, Michael R.; Flohr, Carsten
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
M
Mark I. McCarthy
H-index: 222 · Papers: 1.5K
P
Panos Deloukas
H-index: 197 · Papers: 764
C
Christian Gieger
H-index: 175 · Papers: 942
T
Tōnu Esko
H-index: 165 · Papers: 826
R
Robert Plomin
H-index: 162 · Papers: 1.5K
View more